Seshadri S. Vasan - Concepedia

Author

Seshadri S. Vasan

Australian Centre for Disease Preparedness ORCID

Also Known As

Bansal, Chaarvi, S S Vasan, S Sabari Vasan, S. S. Vasan, S. Sabari Vasan, S. Vasan, S. Vasan, Seshadri, S.S. Vasan, Seshadri S Vasan, Seshadri S. Vasan

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Australian Centre for Disease Preparedness Commonwealth Scientific and Industrial Research Organisation University of York Monash University Peter Doherty Institute

About

Seshadri S. Vasan is an author at Australian Centre for Disease Preparedness specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	1K
2	Public Health	6	6	165
3	Engineering	3	3	45
4	Applied Physics	2	2	30
5	Allergy	1	1	16

Seshadri S. Vasan

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Decay of SARS-CoV-2 and surrogate murine hepatitis virus RNA in untreated wastewater to inform application in wastewater-based epidemiology Warish Ahmed, Paul M. Bertsch, Kyle Bibby, Environmental Research Viral HepatitisHepatitisVirologyMunicipal WastewaterWater Treatment	2020	380
Open Field Release of Genetically Engineered Sterile Male Aedes aegypti in Malaysia Renaud Lacroix, Andrew R. McKemey, Norzahira Raduan, PLoS ONE	2012	237
Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection Ryan J. Farr, Christina L. Rootes, Louise C. Rowntree, PLoS Pathogens Altered Microrna ExpressionViral DiagnosticsSars-cov-2 InfectionMedicineThree-mirna Signature	2021	160
Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein Alexander J. McAuley, Michael J. Kuiper, Peter A. Durr, npj Vaccines VaccinationViral EvolutionVaccine DevelopmentSilico EvidenceVirus Neutralisation Assays	2020	72
ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets Glenn A. Marsh, Alexander J. McAuley, Gough G. Au, npj Vaccines	2021	58
Supporting pandemic response using genomics and bioinformatics: A case study on the emergent SARS‐CoV‐2 outbreak Denis C. Bauer, Aidan P. Tay, Daniel Reti, Transboundary and Emerging Diseases Virus EpidemiologyViral DiagnosticsViral DynamicCovid-19 EpidemiologyCovid-19	2020	51
Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative Sameer Kumar Malladi, Unnatiben Rajeshbhai Patel, Raju S Rajmani, ACS Infectious Diseases Highly ThermotolerantImmunologyImmunodominanceImmunotherapeuticsAntiviral Drug	2021	47
Antiviral Screening of Multiple Compounds against Ebola Virus Stuart Dowall, Kevin R. Bewley, Robert J. Watson, Viruses Medicinal ChemistryNeurovirologyMedicineImmunologyAntiviral Response	2016	46
Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection Ryan J. Farr, Christina L. Rootes, Louise C. Rowntree,	2021	43
Metabolic Profiling from an Asymptomatic Ferret Model of SARS-CoV-2 Infection David J. Beale, Rohan Shah, Avinash V. Karpe, Metabolites Citric Acid CycleLong CovidViral DiagnosticsViral PathogenesisImmunology	2021	34

Page 1